Work

Phase I Study of Aurora A Kinase Inhibitor MLN8237 in Advanced Solid Tumors: Safety, Pharmacokinetics, Pharmacodynamics, and Bioavailability of Two Oral Formulations

Year: 2012

Type: article

Study design: Clinical Trial

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-12-0589

Authors: E. Claire Dees, Roger B. Cohen, Margaret von Mehren, Thomas E. Stinchcombe, Hua Liu, Karthik Venkatakrishnan, Mark Manfredi, Howard Fingert, Howard A. Burris, Jeffrey R. Infante

Institutions: University of North Carolina at Chapel Hill, Fox Chase Cancer Center, UNC Lineberger Comprehensive Cancer Center, Takeda Oncology (United States), University of Pennsylvania

Language: English

Topic: Microtubule and mitosis dynamics

Subfield: Cell Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Takeda Oncology

OpenAlex ID: W1982959429

FWCI: 8.05

Cites: 37

Cited by: 157

Related to: 10